We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

186 hedge funds and large institutions have $621M invested in Heron Therapeutics in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 75 increasing their positions, 47 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

202% more call options, than puts

Call options by funds: $7.75M | Put options by funds: $2.57M

60% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 47

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

7% less funds holding

Funds holding: 200 → 186 (-14)

9.13% less ownership

Funds ownership: 115.41% → 106.28% (-9.1%)

39% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 36

42% less capital invested

Capital invested by funds: $1.07B → $621M (-$453M)

Holders
186
Holders Change
-14
Holders Change %
-7%
% of All Funds
2.93%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
22
Increased
75
Reduced
47
Closed
36
Calls
$7.75M
Puts
$2.57M
Net Calls
+$5.18M
Net Calls Change
+$3.05M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$38.3M
2
Bank of America
Bank of America
North Carolina
+$9.23M
3
Morgan Stanley
Morgan Stanley
New York
+$8.62M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$5M
5
OCM
Orchard Capital Management
Illinois
+$4.4M

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$75.6M
2
TCM
Tang Capital Management
California
-$29.7M
3
SI
Sofinnova Investments
California
-$21.4M
4
RCAMU
Rothschild & Co Asset Management US
Connecticut
-$12.6M
5
Citadel Advisors
Citadel Advisors
Florida
-$10.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
LWANC
176
Laurel Wealth Advisors (North Carolina)
North Carolina
$1K – – –
PA
177
Parallel Advisors
California
$1K – – –
Rockefeller Capital Management
178
Rockefeller Capital Management
New York
$1K – – –
Federated Hermes
179
Federated Hermes
Pennsylvania
$1K +$15 +2 New
AF
180
Advisornet Financial
Minnesota
$1K +$805 +110 New
Macquarie Group
181
Macquarie Group
Australia
$42 – – –
UOC
182
UBS O'Connor
Illinois
– -$75.6M -8,275,000 Closed
RCAMU
183
Rothschild & Co Asset Management US
Connecticut
– -$12.6M -1,379,846 Closed
Balyasny Asset Management
184
Balyasny Asset Management
Illinois
– -$5.5M -602,613 Closed
SEI Investments
185
SEI Investments
Pennsylvania
– -$3.6M -394,473 Closed
AMH
186
Apollo Management Holdings
New York
– -$2.08M -283,859 Closed
CM
187
Crestline Management
Texas
– -$1.7M -185,766 Closed
PAMP
188
Polar Asset Management Partners
Ontario, Canada
– -$1.66M -182,200 Closed
APP
189
Alpha Paradigm Partners
Illinois
– -$1.58M -173,473 Closed
ECM
190
Endurant Capital Management
California
– -$1.51M -165,404 Closed
Toronto Dominion Bank
191
Toronto Dominion Bank
Ontario, Canada
– -$1.2M -163,376 -100%
Jane Street
192
Jane Street
New York
– -$934K -127,575 Closed
E
193
Ergoteles
New York
– -$915K -100,229 Closed
PAM
194
Private Asset Management
California
– -$711K -77,841 Closed
Squarepoint
195
Squarepoint
New York
– -$675K -73,893 Closed
Baird Financial Group
196
Baird Financial Group
Wisconsin
– -$586K -64,155 Closed
CS
197
Candriam SCA
Luxembourg
– -$493K -53,993 Closed
Simplex Trading
198
Simplex Trading
Illinois
– -$284K -38,853 Closed
HF
199
HRT Financial
New York
– -$343K -37,662 Closed
SSA
200
Schonfeld Strategic Advisors
New York
– -$264K -28,900 Closed
5 6 7
8
9

HRTX Hedge Fund Activity: Q1 2022 in Review

186 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q1 2022, worth a combined $621M — down 42% from $1.07B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of HRTX and 22 opened new positions — a net loss of 14 holders — while 47 trimmed existing stakes and 75 added.

The largest buyer was State Street, adding an estimated $38.3M. The largest seller was UBS O'Connor, exiting entirely with an estimated $75.6M sold.

  • 186 institutional investors held Heron Therapeutics (HRTX) as of Q1 2022, down from 200 in Q4 2021.
  • Funds reported $621M of Heron Therapeutics stock for Q1 2022, down 42% quarter-over-quarter.
  • 22 funds opened new Heron Therapeutics positions in Q1 2022 and 36 closed out, a net change of -14 holders.
  • The largest Heron Therapeutics buyer in Q1 2022 was State Street, an estimated $38.3M added.
  • The largest Heron Therapeutics seller in Q1 2022 was UBS O'Connor, an estimated $75.6M sold.

Based on aggregated 13F filings for Q1 2022.